BOSTON SCIENTIFIC CORPORATION Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Accounts Receivable, Change in Method, Credit Loss Expense (Reversal) of $10.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal · last filed 2023-02-23
- BOSTON SCIENTIFIC CORPORATION accounts receivable, change in method, credit loss expense (reversal) for the quarter ending 2020-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION accounts receivable, change in method, credit loss expense (reversal) for the quarter ending 2020-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION accounts receivable, change in method, credit loss expense (reversal) for the quarter ending 2020-06-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION accounts receivable, change in method, credit loss expense (reversal) for the quarter ending 2020-03-31 was $10.00M.
- BOSTON SCIENTIFIC CORPORATION accounts receivable, change in method, credit loss expense (reversal) for fiscal 2020 was $10.00M.
| Period end | Accounts Receivable, Change in Method, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Change in Method, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Change in Method, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Change in Method, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $10.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $10.00M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $10.00M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $10.00M 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |